ArticleCRSLS : MIS case reports from SLS
A Rare Case of Uterine Embryonal Rhabdomyosarcoma.
Article in CRSLS : MIS case reports from SLS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uterine sarcoma is a rare mesenchymal malignancy, and its preoperative diagnosis presents significant challenges, often resulting in the so-called occult sarcoma following surgery, based on the pathological diagnosis. Embryonal rhabdomyosarcoma of the female genital tract most commonly presents in pediatric patients and occurs in the uterine cervix. A pure uterine embryonal rhabdomyosarcoma presenting in an older adult patient is exceedingly rare. Due to its overall poor prognosis, early recognition of this unusual entity is crucial for patient care. Case: A 57-year-old woman presented with a single uterine mass and intermittent bleeding over the past 4-5 years. Office endometrial biopsies, conducted twice by other providers, reported either normal endometrium or inconclusive results; therefore, she was diagnosed and managed as having uterine fibroids for the past 3 years. Given the high suspicion of uterine malignancy, we counseled the patient with a plan for an abdominal hysterectomy and bilateral salpingo-oophorectomy. Meanwhile, we performed another endometrial biopsy under sedation to obtain an adequate and accurate specimen. This biopsy revealed high-grade malignancy, leading to the diagnosis of uterine embryonal rhabdomyosarcoma following the hysterectomy. She is currently undergoing chemotherapy with docetaxel and gemcitabine. Conclusion: Since there is no reliable laboratory or imaging study for preoperative diagnosis of uterine sarcoma, a high index of clinical suspicion is of the utmost importance to decrease the occurrence of occult uterine sarcoma, which is extremely difficult to differentiate from benign uterine fibroids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.